David E. Fisher

49.6k citations

411 papers · 33.8k indexed · 16 hit papers · h-index 92

Impact in

Cell Biology top 0.02%
- melanin and skin pigmentation
Dermatology top 0.05%
- Skin Protection and Aging

Papers in

Cell Biology 108
- melanin and skin pigmentation 98
Dermatology 44
- Skin Protection and Aging 39

Co-authors: Hans R. Widlund Jennifer Y. Lin Scott R. Granter Carmit Levy Keith T. Flaherty Mehdi Khaled Jennifer A. Lo Timothy J. Hemesath
Journals: Nature (26 papers)Journal of Geophysical Research Atmospheres (14 papers)Journal of Biological Chemistry (13 papers)Geochimica et Cosmochimica Acta (13 papers)Cancer Research (12 papers)
Partner nations: United States Japan Germany

In The Last Decade

David E. Fisher

400 papers receiving 32.8k citations

Hit Papers

15 papers align trajectories log scale

Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy 2019 · 438 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Immunity
2017 Nature
2015 Nature Reviews Disease Primers
2014 Cancer Discovery
2013 Cancer Cell
2012 Nature
2010 Cancer Research
2007 Nature
2006 Trends in Molecular Medicine
2005 Nature
2004 Science
2002 Cell
1998 Nature
1994 Science
1994 Genes & Development
1994 Cell

Peers

Countries citing papers authored by David E. Fisher

Since Specialization

Citations

This map shows the geographic impact of David E. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Fisher more than expected).

Fields of papers citing papers by David E. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Fisher. The network helps show where David E. Fisher may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Fisher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Fisher Line = papers co-authored together David E. Fisher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Removal of hexavalent chromium from aqueous solutions by sorption with activated carbon. Review Bagdaulet Kenzhaliyev, Riley Leary, David E. Fisher, Ann Urmston	2024	2
2	Commensurators of normal subgroups of lattices French digital mathematics library (Numdam) ·David E. Fisher, Ursula Gröttrub, Olga Ermilova	2024	0
3	β-Endorphin mediates radiation therapy fatigue Science Advances ·Soledad Salinas-Whittaker, Gillian L. Fell, Lajos V. Kemény, Claire Y. Fung, Kathryn D. Held, Peter J. Biggs, Phillip D. Rivera, Staci D. Bilbo, Vivien Igras, Henning Willers, Jong Kung, Liliana Gheorghiu, Katalin Hidéghety, Jianren Mao, Clifford J. Woolf, David E. Fisher	2022	7
4	Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death Molecular Cancer Therapeutics ·S. Einbu, Mandeep Kaur Gondara, Shinichiro Kato, David E. Fisher, Hiroaki Sakurai, Yoshihiro Hayakawa, Satoru Yokoyama	2019	10
5	MITF and UV responses in skin: From pigmentation to addiction Pigment Cell & Melanoma Research ·Nathalie T. Nguyen, David E. Fisher	2018	107
6	Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations Clinical Cancer Research ·Adam A. Friedman, Yun Xia, Lorenzo Trippa, Long P. Le, Vivien Igras, Dennie T. Frederick, Jennifer A. Wargo, Kenneth K. Tanabe, Donald P. Lawrence, Donna Neuberg, Keith T. Flaherty, David E. Fisher	2017	5
7	The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1 -Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity Cancer Research ·Kensuke Tateishi, Fumi Higuchi, Julie J. Miller, Mara V.A. Koerner, Nina Lelic, Ganesh M. Shankar, Shota Tanaka, David E. Fisher, Tracy T. Batchelor, A. John Iafrate, Hiroaki Wakimoto, S. Andrew, Daniel P. Cahill	2017	73
8	Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas Proceedings of the National Academy of Sciences ·Wanlu Du, Ivan Seah, Jan Bergner, P. Rossini, Katrina Meeth, Marcus Bosenberg, Hiroaki Wakimoto, David E. Fisher, Khalid Shah	2017	100
9	ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM Molecular Cancer Research ·Xuesong Liu, Matthew Genet, Jenna E. Haines, Gagan B. Mohanty, Shaowei Wu, Hung-I Harry Chen, Yidong Chen, Abrar A. Qureshi, Jiali Han, Xiang Chen, David E. Fisher, Pier Paolo Pandolfi, Zhi-Min Yuan	2015	34
10	Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53 Science ·Kyoung Wan Yoon, Sanguine Byun, Eun‐Jeong Kwon, So-Young Hwang, Kiki Chu, Masatsugu Hiraki, Indah Karunia Fitri, Astrid Weins, Samy Hakroush, A. Cebulla, David B. Sykes, Anna Greka, Peter Mündel, David E. Fisher, Anna Mandinova, Sam W. Lee	2015	174
11	Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade Cancer Immunology Research ·Zachary A. Cooper, Vikram R. Juneja, Peter T. Sage, Dennie T. Frederick, Adriano Piris, Devarati Mitra, Jennifer A. Lo, F. Stephen Hodi, Gordon J. Freeman, Marcus Bosenberg, Martin McMahon, Keith T. Flaherty, David E. Fisher, Arlene H. Sharpe, Jennifer A. Wargo	2014	192
12	Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab Clinical Cancer Research ·Yvonne M. Saenger, Jay Magidson, Miguel Garcia Garces, Juan José Pardo García-Valdecasas, Joseph Ssenkumba, Yichun Fu, 壽美子大島, David E. Fisher, John M. Kirkwood, William Oh, Philip Friedlander	2014	31
13	A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors Cancer Discovery ·David J. Konieczkowski, Cory M. Johannessen, Omar O. Abudayyeh, Jong Wook Kim, Zachary A. Cooper, Adriano Piris, Dennie T. Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq, David E. Fisher, Jill P. Mesirov, William C. Hahn, Keith T. Flaherty, Jennifer A. Wargo, Pablo Tamayo, Levi A. Garraway Hit paper breakdown →	2014	357
14	YY1 regulates melanocyte development and function by cooperating with MITF eScholarship (California Digital Library) ·Jun S. Song, (unknown), Robert J.A. Bell, (unknown), (unknown), (unknown), Kevin T. Love, (unknown), Daniel G. Anderson, (unknown), David E. Fisher	2012	37
15	An Oncogenic Role for ETV1 in Melanoma Cancer Research ·Judit Jané‐Valbuena, Hans R. Widlund, Sven Perner, Laura A. Johnson, Ana Andreea Gurita Harja, William M. Lin, Alissa C. Baker, Rosalynn M. Nazarian, Krishna G. Vijayendran, William R. Sellers, William C. Hahn, Lyn M. Duncan, Mark A. Rubin, David E. Fisher, Levi A. Garraway	2010	81
16	Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function Cancer Research ·Andrea Boni, Alexandria P. Cogdill, Ping Dang, Durga Udayakumar, Ching-Ni Jenny Njauw, Callum M. Sloss, Cristina R. Ferrone, Keith T. Flaherty, Donald P. Lawrence, David E. Fisher, Hensin Tsao, Jennifer A. Wargo Hit paper breakdown →	2010	574
17	Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma Cancer Research ·Ian J. Davis, Andrew W. McFadden, Yixiang Zhang, Angela Coxon, Teresa L. Burgess, Andrew J. Wagner, David E. Fisher	2010	88
18	Mechanism of Regulation and Suppression of Melanoma Invasiveness by Novel Retinoic Acid Receptor-γ Target Gene Carbohydrate Sulfotransferase 10 Cancer Research ·Xiansi Zhao, Yao Zhi-dong, Galilleu Silva, David E. Fisher, Remco A. Spanjaard	2009	23
19	TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition Cancer Research ·Masumi Tsuda, Ian J. Davis, Pedram Argani, Neerav Shukla, Gaël McGill, Makoto Nagai, Tsuyoshi Saito, Marick Laé, David E. Fisher, Marc Ladanyi	2007	217
20	Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche Science ·Emi K. Nishimura, Scott R. Granter, David E. Fisher Hit paper breakdown →	2004	533

About David E. Fisher

David E. Fisher is a scholar working on Cell Biology, Dermatology, Oncology, Immunology and Sensory Systems, having authored 411 papers that have together received 33.8k indexed citations. Recurring topics across this work include melanin and skin pigmentation (98 papers), Melanoma and MAPK Pathways (61 papers), Skin Protection and Aging (39 papers), Astro and Planetary Science (30 papers), Immunotherapy and Immune Responses (26 papers), Biochemical Analysis and Sensing Techniques (26 papers), Cancer-related Molecular Pathways (25 papers) and CAR-T cell therapy research (25 papers). The work is most often cited by research in Cell Biology (9.6k citations), Dermatology (3.6k citations), Oncology (9.9k citations), Cancer Research (4.4k citations) and Immunology (5.8k citations). David E. Fisher has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Hans R. Widlund, Jennifer Y. Lin, Scott R. Granter, Carmit Levy, Keith T. Flaherty, Mehdi Khaled, Jennifer A. Lo, Timothy J. Hemesath, Emi K. Nishimura and Levi A. Garraway. Their work appears in journals such as Nature, Journal of Geophysical Research Atmospheres, Journal of Biological Chemistry, Geochimica et Cosmochimica Acta and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact